Centralized pan-Russian Survey on the undertreatment of hypercholesterolemia - CEPHEUS
Study identifier:NIS-CRU-DUM-2010/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Centralized pan-Russian Survey on the undertreatment of hypercholesterolemia
Medical condition
dyslipidaemia
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
1000
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Oct 2010
Primary Completion Date: 01 Mar 2011
Study Completion Date: 01 Mar 2011
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Subject 18 years of age or older on lipid lowering drug treatment for at least 3 months, with no dose change for a minimum of 6 weeks.. | - |
Contacts
Investigators
Principal Investigator
Alexey Stepanov
AstraZeneca
